Cullinan Therapeutics: Q4 Earnings Insights

Cullinan Therapeutics (NASDAQ:CGEM) just disclosed its Q4 earnings on Tuesday, March 10, 2026 at 07:00 AM.

Here's a brief overview of the earnings report.

Earnings

Cullinan Therapeutics beat estimated earnings by 6.1%, reporting an EPS of $-0.77 versus an estimate of $-0.82.

Revenue was down $0 from the same period last year.

Past Earnings Performance

During the previous quarter, the company beat on EPS by $0.15, leading to a 2.18% drop share price change the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Cullinan Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.